Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/21/2024 | $20.00 → $28.00 | Hold → Buy | Deutsche Bank |
| 5/3/2024 | Neutral → Outperform | Wedbush | |
| 4/26/2024 | $19.00 → $21.00 | Neutral → Outperform | Exane BNP Paribas |
| 4/22/2024 | $22.00 | Buy | Mizuho |
| 4/1/2024 | $18.00 → $25.00 | Underperform → Buy | BofA Securities |
| 3/25/2024 | $19.00 | Equal Weight | Wells Fargo |
| 3/8/2024 | $21.00 | Outperform | RBC Capital Mkts |
| 1/5/2024 | Overweight → Sector Weight | KeyBanc Capital Markets |
8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)
8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)
10-Q - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- American Homes 4 Rent (NYSE:AMH) will replace Physicians Realty Trust (NYSE:DOC) in the S&P MidCap 400 effective prior to the opening of trading on Friday, March 1. S&P 500 constituent Healthpeak Properties Inc. (NYSE:PEAK) is acquiring Physicians Realty Trust in a deal expected to be completed soon pending final conditions. Post-merger, Healthpeak Properties will have a symbol change from PEAK to DOC. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector March 1, 2024 S&P MidCap 400 Addition American Homes 4 Rent AMH Real E
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced it increased full year 2024 guidance, driven by the continued strong performance of its high-quality lab, outpatient medical, and CCRC portfolios. Healthpeak's updated guidance ranges include: Diluted FFO as Adjusted per share increased from $1.79 – $1.81 to $1.80 – $1.82 Diluted AFFO per share increased from $1.56 – $1.58 to $1.57 – $1.59 Total Merger-Combined Same-Store Cash (Adjusted) NOI growth increased from 3.5% – 4.5% to 4.0% – 5.0% Healthpeak published an updated Investor Presentation to incorporate the above-mentioned guidance
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced the publication of an investor presentation in advance of upcoming investor meetings. The presentation is available on Healthpeak's investor relations website at https://ir.healthpeak.com. ABOUT HEALTHPEAK PROPERTIES Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates and develops high-quality real estate focused on healthcare discovery and delivery. For more information regarding Healthpeak, visit www.healthpeak.com. View source version on businesswire.com: https:/
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the third quarter ended September 30, 2024. THIRD QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.12 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.45 per share, AFFO of $0.41 per share, and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4.1% Increased the midpoint of both 2024 FFO as Adjusted and AFFO guidance by +$0.01 per share, and increased Total Merger-Combined Same-Store Cash (Adjusted) NOI growth guidance by +50 basis points at the midpoint Increased expecte
SC 13G/A - HEALTHPEAK PROPERTIES, INC. (0000765880) (Subject)
SC 13G - Physicians Realty Trust (0001574540) (Subject)
SC 13G/A - Physicians Realty Trust (0001574540) (Subject)
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the third quarter ended September 30, 2024. THIRD QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.12 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.45 per share, AFFO of $0.41 per share, and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4.1% Increased the midpoint of both 2024 FFO as Adjusted and AFFO guidance by +$0.01 per share, and increased Total Merger-Combined Same-Store Cash (Adjusted) NOI growth guidance by +50 basis points at the midpoint Increased expecte
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report its third quarter 2024 financial results after the close of trading on the New York Stock Exchange on Thursday, October 24, 2024. Healthpeak will host a conference call and webcast on Friday, October 25, 2024, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and operating results. The conference call can be accessed in the following ways: Healthpeak's website: https://ir.healthpeak.com/news-events Webcast: https://events.q4inc.com/attendee/713594150. Joining via webcast is recommended f
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the second quarter ended June 30, 2024. SECOND QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.21 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.45 per share, AFFO of $0.39 per share, and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4.5% Increased full year 2024 diluted earnings guidance to a range of $0.27 – $0.31 per share; increased the midpoint of each 2024 FFO as Adjusted and AFFO guidance by +$0.01 per share, and increased Total Merger-Combined Same-Store C
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
Deutsche Bank upgraded Healthpeak Properties from Hold to Buy and set a new price target of $28.00 from $20.00 previously
Wedbush upgraded Healthpeak Properties from Neutral to Outperform
Exane BNP Paribas upgraded Healthpeak Properties from Neutral to Outperform and set a new price target of $21.00 from $19.00 previously
Healthpeak Properties's (NYSE:DOC) short percent of float has fallen 11.06% since its last report. The company recently reported that it has 10.30 million shares sold short, which is 1.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.84 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short
Healthpeak Properties's (NYSE:DOC) short percent of float has fallen 3.7% since its last report. The company recently reported that it has 11.55 million shares sold short, which is 2.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.37 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short i
Analysts' ratings for Healthpeak Properties (NYSE:DOC) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 2 0 0 Last 30D 0 1 1 0 0 1M Ago 1 0 0 0 0 2M Ago 1 1 1 0 0 3M Ago 0 1 0 0 0 Analysts have recently evaluated Healthpeak Properties and provided 12-month price targets. The average target is $21.86, accompanied by a high estimate of $25.00 and a low estimate of $19.00. Witnessing a positive shift, th